Precision Cancer Diagnostic Tests Market 2027 By Product Type, End User and Geography | The Insight Partners

Precision Cancer Diagnostic Tests Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Imaging, Molecular, Tumor Marker Immunoassays, POC Colon Cancer Tests); End User (Hospital, Clinic, Other) and Geography

Report Code: TIPRE00017625 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
Covid
MARKET INTRODUCTION

Precision Cancer Diagnostic Tests involves the imaging, in- vitro diagnostic tests and procedures which detect malignancies and cancer progression in patient's tissue sample. These precision cancer diagnostic tests have also important role in staging of cancer which makes it super reliable. The precision cancer diagnostic tests are also used for monitoring and evaluation of ongoing cancer treatment on patient i.e. to check whether disease is responding to treatment or not.

MARKET DYNAMICS

The key market drivers for Precision Cancer Diagnostic Tests Market Includes, rising prevalence of cancer cases globally such as, solid tumors, blood malignancies along with increase in awareness about routine health checkup for early detection of such a diseases. Moreover, technological advancement in diagnostic methods is also expected to fuel market growth during the forecast period.

MARKET SCOPE

The "Precision Cancer Diagnostic Tests Market" is a specialized and in-depth study of the Healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Precision Cancer Diagnostic Tests market with detailed market segmentation by product type and end user. The Precision Cancer Diagnostic Tests Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Precision Cancer Diagnostic Tests Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Precision Cancer Diagnostic Tests Market is segmented on the basis of product type and end user. On the basis of product type the market is segmented as, imaging, molecular, tumor marker immunoassays, POC colon cancer tests. And on the basis of end user the market is segmented as, hospital, clinics and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Precision Cancer Diagnostic Tests Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Precision Cancer Diagnostic Tests Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Precision Cancer Diagnostic Tests Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Precision Cancer Diagnostic Tests Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Precision Cancer Diagnostic Tests Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Precision Cancer Diagnostic Tests Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Precision Cancer Diagnostic Tests market in the global market. Below mentioned is the list of few companies engaged in the Precision Cancer Diagnostic Tests Market.

The report also includes the profiles of key players in Precision Cancer Diagnostic Tests Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Abbott Laboratories
  •   Agilent Technologies, Inc.
  •   BD
  •   Bio-Rad Laboratories Inc.
  •   Biocartis N.V
  •   bioMerieux SA
  •   Danaher Corporation
  •   Hologic Inc.
  •   QIAGEN N.V
  •   Thermo Fisher Scientific

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Precision Cancer Diagnostic Tests Market - By Product Type
1.3.2 Precision Cancer Diagnostic Tests Market - By End User
1.3.3 Precision Cancer Diagnostic Tests Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PRECISION CANCER DIAGNOSTIC TESTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PRECISION CANCER DIAGNOSTIC TESTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PRECISION CANCER DIAGNOSTIC TESTS MARKET - GLOBAL MARKET ANALYSIS
6.1. PRECISION CANCER DIAGNOSTIC TESTS - GLOBAL MARKET OVERVIEW
6.2. PRECISION CANCER DIAGNOSTIC TESTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PRECISION CANCER DIAGNOSTIC TESTS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. IMAGING
7.3.1. Overview
7.3.2. Imaging Market Forecast and Analysis
7.4. MOLECULAR
7.4.1. Overview
7.4.2. Molecular Market Forecast and Analysis
7.5. TUMOR MARKER IMMUNOASSAYS
7.5.1. Overview
7.5.2. Tumor Marker Immunoassays Market Forecast and Analysis
7.6. POC COLON CANCER TESTS
7.6.1. Overview
7.6.2. POC Colon Cancer Tests Market Forecast and Analysis
8. PRECISION CANCER DIAGNOSTIC TESTS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis

9. PRECISION CANCER DIAGNOSTIC TESTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Precision Cancer Diagnostic Tests Market Overview
9.1.2 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.1.3 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.1.4 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.1.5 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.1.5.1 United States Precision Cancer Diagnostic Tests Market
9.1.5.1.1 United States Precision Cancer Diagnostic Tests Market by Product Type
9.1.5.1.2 United States Precision Cancer Diagnostic Tests Market by End User
9.1.5.2 Canada Precision Cancer Diagnostic Tests Market
9.1.5.2.1 Canada Precision Cancer Diagnostic Tests Market by Product Type
9.1.5.2.2 Canada Precision Cancer Diagnostic Tests Market by End User
9.1.5.3 Mexico Precision Cancer Diagnostic Tests Market
9.1.5.3.1 Mexico Precision Cancer Diagnostic Tests Market by Product Type
9.1.5.3.2 Mexico Precision Cancer Diagnostic Tests Market by End User
9.2. EUROPE
9.2.1 Europe Precision Cancer Diagnostic Tests Market Overview
9.2.2 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.2.3 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.2.4 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.2.5 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Precision Cancer Diagnostic Tests Market
9.2.5.1.1 Germany Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.1.2 Germany Precision Cancer Diagnostic Tests Market by End User
9.2.5.2 France Precision Cancer Diagnostic Tests Market
9.2.5.2.1 France Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.2.2 France Precision Cancer Diagnostic Tests Market by End User
9.2.5.3 Italy Precision Cancer Diagnostic Tests Market
9.2.5.3.1 Italy Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.3.2 Italy Precision Cancer Diagnostic Tests Market by End User
9.2.5.4 Spain Precision Cancer Diagnostic Tests Market
9.2.5.4.1 Spain Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.4.2 Spain Precision Cancer Diagnostic Tests Market by End User
9.2.5.5 United Kingdom Precision Cancer Diagnostic Tests Market
9.2.5.5.1 United Kingdom Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.5.2 United Kingdom Precision Cancer Diagnostic Tests Market by End User
9.2.5.6 Rest of Europe Precision Cancer Diagnostic Tests Market
9.2.5.6.1 Rest of Europe Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.6.2 Rest of Europe Precision Cancer Diagnostic Tests Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Overview
9.3.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.3.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Precision Cancer Diagnostic Tests Market
9.3.5.1.1 Australia Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.1.2 Australia Precision Cancer Diagnostic Tests Market by End User
9.3.5.2 China Precision Cancer Diagnostic Tests Market
9.3.5.2.1 China Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.2.2 China Precision Cancer Diagnostic Tests Market by End User
9.3.5.3 India Precision Cancer Diagnostic Tests Market
9.3.5.3.1 India Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.3.2 India Precision Cancer Diagnostic Tests Market by End User
9.3.5.4 Japan Precision Cancer Diagnostic Tests Market
9.3.5.4.1 Japan Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.4.2 Japan Precision Cancer Diagnostic Tests Market by End User
9.3.5.5 South Korea Precision Cancer Diagnostic Tests Market
9.3.5.5.1 South Korea Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.5.2 South Korea Precision Cancer Diagnostic Tests Market by End User
9.3.5.6 Rest of Asia-Pacific Precision Cancer Diagnostic Tests Market
9.3.5.6.1 Rest of Asia-Pacific Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Precision Cancer Diagnostic Tests Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Precision Cancer Diagnostic Tests Market Overview
9.4.2 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.4.3 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Precision Cancer Diagnostic Tests Market
9.4.5.1.1 South Africa Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.1.2 South Africa Precision Cancer Diagnostic Tests Market by End User
9.4.5.2 Saudi Arabia Precision Cancer Diagnostic Tests Market
9.4.5.2.1 Saudi Arabia Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.2.2 Saudi Arabia Precision Cancer Diagnostic Tests Market by End User
9.4.5.3 U.A.E Precision Cancer Diagnostic Tests Market
9.4.5.3.1 U.A.E Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.3.2 U.A.E Precision Cancer Diagnostic Tests Market by End User
9.4.5.4 Rest of Middle East and Africa Precision Cancer Diagnostic Tests Market
9.4.5.4.1 Rest of Middle East and Africa Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Precision Cancer Diagnostic Tests Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Precision Cancer Diagnostic Tests Market Overview
9.5.2 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.5.3 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.5.5 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Precision Cancer Diagnostic Tests Market
9.5.5.1.1 Brazil Precision Cancer Diagnostic Tests Market by Product Type
9.5.5.1.2 Brazil Precision Cancer Diagnostic Tests Market by End User
9.5.5.2 Argentina Precision Cancer Diagnostic Tests Market
9.5.5.2.1 Argentina Precision Cancer Diagnostic Tests Market by Product Type
9.5.5.2.2 Argentina Precision Cancer Diagnostic Tests Market by End User
9.5.5.3 Rest of South and Central America Precision Cancer Diagnostic Tests Market
9.5.5.3.1 Rest of South and Central America Precision Cancer Diagnostic Tests Market by Product Type
9.5.5.3.2 Rest of South and Central America Precision Cancer Diagnostic Tests Market by End User

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PRECISION CANCER DIAGNOSTIC TESTS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AGILENT TECHNOLOGIES INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIO-RAD LABORATORIES INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIOCARTIS N.V
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIOMERIEUX SA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. DANAHER CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HOLOGIC INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. QIAGEN N.V.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. THERMO FISHER SCIENTIFIC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Agilent Technologies Inc.
3. BD
4. Bio-Rad Laboratories Inc.
5. Biocartis N.V
6. bioMerieux SA
7. Danaher Corporation
8. Hologic Inc.
9. QIAGEN N.V.
10. Thermo Fisher Scientific
TIPRE00017625
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking